Pancreatic disease

Disease1 paper1 finding

Humans1

Associations

1

PhenoAgeAccel

upin humans1HR 1.706

1 study

PhenoAgeAccel raises the risk of pancreatic disease in humans (HR 1.706, 95% CI 1.513-1.923).
Humansfully adjusted Cox model, compared with G1
Biological aging, circulating lipid biomarkers and pancreatic diseases: a prospective cohort study based on the UK Biobank · The journal of nutrition, health & aging · 15 Sep 2026

PhenoAgeAccel →

Trial sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1 trialPhase 1/248 people

Latest

3

The Journal of Nutrition, Health & AgingHumans15 Sep

Biological aging, circulating lipid biomarkers and pancreatic diseases: a prospective cohort study based on the UK Biobank

PLOS OneResearch9 Sep

Impact of GLP-1 receptor agonists on patients with intraductal papillary mucinous neoplasms: Study protocol for a multicentric cohort study

Aging and DiseaseHumans3 Sep

A Pathology-Trained Lipid Aging Clock Reveals Accelerated Aging and Prognostic Sphingolipid Signatures in Pancreatic Disease